Related Experiment Video

Updated: Jun 26, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

Intraarticular triamcinolone in juvenile idiopathic arthritis

Erbil Unsal1, Balahan Makay

  • 1Department of Pediatrics, Dokuz Eylul University Hospital, Division of Immunology and Rheumatology, 35340 Balcova, Izmir, Turkey.

Indian Pediatrics
|January 9, 2009
PubMed

Insights

Intra-articular triamcinolone acetonide injections effectively treat juvenile idiopathic arthritis (JIA) joint inflammation and contractures. Remission rates were highest in oligoarticular JIA, showing this therapy

Area of Science:

  • Pediatric Rheumatology
  • Orthopedic Surgery
  • Pharmacology

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children's joints.
  • Intra-articular corticosteroid injections are a common treatment modality for localized JIA.
  • Triamcinolone acetonide (TA) is frequently used for its sustained anti-inflammatory effects.

Purpose of the Study:

  • To evaluate the efficacy and safety of intra-articular triamcinolone acetonide (TA) injections in children with JIA.
  • To assess remission rates of joint inflammation and success in treating joint contractures.
  • To compare treatment outcomes across different subtypes of JIA.

Main Methods:

  • Retrospective evaluation of 37 children with JIA receiving one or more intra-articular TA injections.
  • Analysis of 125 injections across 95 affected joints.
  • Assessment of complete remission of joint inflammation (≥6 months) and treatment of joint contractures.

Main Results:

  • Complete remission of joint inflammation was achieved in 65% of injections (62/95) lasting at least 6 months.
  • Successful treatment of joint contractures occurred in 69% of joints (35/51).
  • Significantly higher remission rates (81%, 21/26) were observed in oligoarticular JIA compared to other subtypes (59%, 41/69; P<0.01).

Conclusions:

  • Intra-articular TA injections represent an effective and safe therapeutic option for managing inflammatory joint disease in JIA.
  • The oligoarticular subtype of JIA demonstrates a particularly favorable response to intra-articular TA therapy.
  • This treatment can lead to sustained joint inflammation remission and improvement in joint contractures.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Ankle Joint01:10

Ankle Joint

The ankle is formed by the talocrural joint (crural = leg). It consists of the articulations between the talus bone of the foot and the distal ends of the tibia and fibula of the leg. The superior aspect of the talus bone is square-shaped and has three areas of articulation. The top of the talus articulates with the inferior tibia. This is the portion of the ankle joint that carries the body weight between the leg and foot. The sides of the talus are firmly held in position by the articulations...